We at Colzyx believe that by developing WOUNDCOM, a bioactive wound dressing, we can address this emerging problem, contribute to a better quality of life and make a difference in the fight against multidrug-resistant bacteria. WOUNDCOM has a proven dual function of accelerating wound healing and having a pronounced effect on a wide range of bacterial infections, including multidrug-resistant bacteria. Hence, WOUNDCOM represents advanced wound care with specific tissue regeneration properties. We are making use of the human body's own wound healing and antibacterial processes. We have identified, isolated and further developed key molecules from the human innate immune system that are produced in the natural wound healing process. The addition of these molecules in the form of WOUNDCOM to a wound, has been shown to accelerate the natural wound healing process and synergistically kill bacteria that invade the wound. WOUNDCOM is presently being developed with the aim to be registered as a medical device and will be evaluated in clinical trials focusing on the healing of chronic wounds.
View Top Employees from ColzyxWebsite | http://www.colzyx.com |
Revenue | $3 million |
Employees | 7 (4 on RocketReach) |
Founded | 2016 |
Address | 1 Scheeletorget, Lund, Skane 223 63, SE |
Industry | Biotechnology Research, Business Services General, Medical, Business Services, Health Care |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 541714 Companies |
Looking for a particular Colzyx employee's phone or email?
The Colzyx annual revenue was $3 million in 2023.
Karin Bryder is the CEO of Colzyx.
4 people are employed at Colzyx.
Colzyx is based in Lund, Skane.
The NAICS codes for Colzyx are [54, 54171, 5417, 541, 541714].
The SIC codes for Colzyx are [873, 87].